drugset / Trial / NCT03760263
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
RandomizedParallel-groupOpen-labelSupportive care
Summary
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Timeline
- Start
- 2020-01-16
- Primary completion
- 2023-11-01
- Completion
- 2023-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | 4 mg | Oral |
| Comparator | Tacrolimus | Small molecule | 8 mg | Oral |
Indications
No indication recorded.